Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

For the first time, scientists have made a clear X-ray detection of chlorine and potassium in the wreckage of a star using ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...

Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...

Are you preparing for UPSC CSE Prelims 2026? Check your progress and revise your topics through this quiz on Science and ...

This one-step plan promises to permanently fix high cholesterol levels.

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a once-and-done treatment paradigm for diseases with ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

As the global population ages and the disease burden climbs ever higher, more patients than ever before could benefit from cell and gene therapy (CGT) treatments. When the CRISPR-Cas9 technology was ...

In 2023, FDA approved one CRISPR/Cas9-based gene therapy to treat sickle cell disease, which marks a significant milestone in the translation of genome editing technologies into clinical therapeutics.